Skip to Main content Skip to Navigation
New interface
Journal articles

HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice.

Abstract : Effective control of HIV-1 infection in humans is achieved using combinations of antiretroviral therapy (ART) drugs. In humanized mice (hu-mice), control of viremia can be achieved using either ART or by immunotherapy using combinations of broadly neutralizing antibodies (bNAbs). Here we show that treatment of HIV-1-infected hu-mice with a combination of three highly potent bNAbs not only resulted in complete viremic control but also led to a reduction in cell-associated HIV-1 DNA. Moreover, lowering the initial viral load by coadministration of ART and immunotherapy enabled prolonged viremic control by a single bNAb after ART was withdrawn. Similarly, a single injection of adeno-associated virus directing expression of one bNAb produced durable viremic control after ART was terminated. We conclude that immunotherapy reduces plasma viral load and cell-associated HIV-1 DNA and that decreasing the initial viral load enables single bNAbs to control viremia in hu-mice.
Keywords : CD4bs glycan gp160
Complete list of metadata

https://hal-pasteur.archives-ouvertes.fr/pasteur-01109449
Contributor : Isma Ziani Connect in order to contact the contributor
Submitted on : Monday, January 26, 2015 - 1:27:02 PM
Last modification on : Tuesday, May 31, 2022 - 10:20:13 AM

Links full text

Identifiers

Collections

Citation

Joshua A Horwitz, Ariel Halper-Stromberg, Hugo Mouquet, Alexander D Gitlin, Anna Tretiakova, et al.. HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice.. Proceedings of the National Academy of Sciences of the United States of America, 2013, 110 (41), pp.16538-43. ⟨10.1073/pnas.1315295110⟩. ⟨pasteur-01109449⟩

Share

Metrics

Record views

362